Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2025 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $5.9 billion (+11.9%)
Orthopedics: $2.3 billion (+9.7%)
Hips: $443 million (+12.7%)
Knees: $639 million (+8.7%)
Spine: $166 million (-2.9%)
Net earnings: $654 million
Total sales: $1.9 billion (+1.1%)
Hips: $495 million (+0.9%)
Knees: $729.9 million (+0.6%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $470.5 million (+3.9%)
Net earnings: $182 million
Medtech sales: $8 billion (+2.5%)
Orthopedic: $2.2 billion (-4.2%)
Spine, sports and other: $671 million (-10.8%)
Hips: $409 million (-3.1%)
Knees: $389 million (-3%)
Net earnings: $11 billion
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.